• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Electroconvulsive Therapy Could Be Better Than Ketamine At Treating Depression

October 24, 2022 by Deborah Bloomfield

Electroconvulsive therapy (ECT) may not be the most palatable of treatment options, but new research indicates that the seizure-inducing technique may be more effective than ketamine at alleviating depression. Researchers pooled data from six separate studies, finding that ECT was in fact superior to ketamine in every trial they looked at.

Over the past few years, ketamine has emerged as a highly promising treatment for depression, with several studies highlighting its remarkably rapid effects. Capable of providing relief within 24 hours of administration, the drug is not currently licensed for medical use, although a related compound called eskatamine has been approved by the US Food and Drug Administration (FDA).

Advertisement

Despite the recent hype around ketamine, however, the study authors point out that ECT is still “considered the gold standard treatment for [depression] because of its proven high efficacy.” At the same time, they concede that the method is not particularly appealing to patients, as it requires the use of anesthesia and involves passing an electrical current through the skull in order to produce a generalized seizure.

To compare the efficacy of ketamine and ECT, the researchers analyzed the results of six studies conducted in Sweden, Germany, Iran, and India, of which five were randomized clinical trials. The studies included a combined total of 340 patients, 162 of whom underwent ECT for depression while the remaining 178 received ketamine.

“Every single study directly reports ECT works better than ketamine,” explained study author Taeho Greg Rhee in a statement. Based on this result, the researchers conclude that “ECT may be superior to ketamine for improving depression severity in the acute phase,” although they also state that “treatment options should be individualized and patient-centered.”

Advertisement

For instance, they mention that patients who require instant relief may benefit more from ketamine, since the drug was reported to provide more rapid anti-depressant effects than ECT in three separate studies. In contrast, ECT was found to be faster-acting in only one study.

The authors also point out that the two treatment options were associated with very different side effects, and that certain patients may therefore be better suited to one over the other. Ketamine, for example, was more likely to produce blurred vision, vertigo, and transient dissociative symptoms, while ECT was linked to headaches and muscle pain.

Furthermore, as Rhee points out, “people are still skeptical of ECT, perhaps because of stigma.” Famously utilized to pacify the fiery Randle McMurphy in Ken Keysey’s novel One Flew Over The Cuckoo’s Nest – later portrayed on screen by Jack Nicholson – the invasive technique is likely to be less appealing than ketamine to many patients.

Advertisement

Despite this assumption, though, the researchers say that none of the six studies reported on patients’ willingness to undergo either of these therapies. Therefore, they urge future studies to “consider patient tolerability and acceptability with respect to these two potential treatments.”

The study was published in the journal JAMA Psychiatry.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Epic Games says it is appealing ruling in Apple case
  2. N.M. Rep. Herrell: Democrats demonizing Border Patrol
  3. Memorial held for Gabby Petito as search continues
  4. Mexico will reject private lithium deals even if reform bill fails -president

Source Link: Electroconvulsive Therapy Could Be Better Than Ketamine At Treating Depression

Filed Under: News

Primary Sidebar

  • “An Unimaginable Breakthrough”: Loudest-Ever Gravitational Wave Collision Proves Stephen Hawking Correct
  • Exciting Martian Mudstone Has Features That Might Be Considered Biosignatures
  • How Long Did Dinosaurs Live? “It’s A Big Surprise To People That Work On Them”
  • NASA’s Mysterious Announcement: “Clearest Sign Of Life That We’ve Ever Found On Mars”
  • New Brain Implant Can Decode Your Internal Monologue, Raising Fears Of Mind Reading
  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • How Does 2-In-1 Shampoo And Conditioner Work?
  • There Are 2-Billion-Year-Old “Millennium Rocks” In A Suburb, Hundreds Of Miles From Their Primeval Home
  • “That’s A Hellfire Missile Smacking Into That UFO”: Strange Video Emerges From US UAP Hearing
  • In 40,000 Years, Voyager 1 Will Have A Close Encounter With Gliese 445
  • Abnormally Long Gamma Ray Burst Unlike Anything We’ve Seen Before Baffles Astronomers
  • Critically Endangered Shark Meat Is Being Sold In US Stores For As Little As $2.99
  • Infectious Mouth Bacteria Lurking In Artery Plaques Could Be Behind Some Heart Attacks
  • What Would You Reach If You Kept Digging Under Antarctica?
  • First Visible Time Crystals Ever Made Have Astonishing Complexity And Practical Potential
  • “Something Undeniably Special”: The Chi Cygnids, A New Five-Yearly Meteor Shower, Peak This Month
  • A 200-Meter-Tall Event We Didn’t See Sent Signals Through The Earth For Nine Whole Days
  • Why Are So Many Volcanoes Underwater?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version